Form 4: Thermo Fisher Scientific Entities Report Disposition of Science 37 Holdings Shares
SEC Form 4 Filing
Thermo Fisher Scientific and related entities report the disposition of 868,990 shares of Science 37 Holdings common stock at $5.75 per share following a reverse stock split.
Summary
- Thermo Fisher Scientific Inc. and several related entities jointly filed a Form 4 regarding changes in beneficial ownership of Science 37 Holdings, Inc. common stock.
- The report indicates the disposition of 868,990 shares of common stock on March 12, 2024, at a price of $5.75 per share.
- The filing is made by multiple reporting persons, including Thermo Fisher Scientific Inc., its subsidiaries, and holding companies, due to potential group status under Section 13(d)(3) of the Securities Exchange Act of 1934.
- The shares were held of record by Pharmaceutical Product Development, LLC (Pharma LLC), with ownership traced through a chain of holding companies ultimately controlled by Thermo Fisher Scientific Inc.
- The filing also references a 1-for-20 reverse stock split of Science 37 Holdings, Inc. common stock that occurred on December 8, 2023, which adjusted the share count.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of significant shareholders and insiders. This filing indicates a change in Thermo Fisher Scientific's investment in Science 37 Holdings.
Key Dates
| Date | Description |
|---|---|
| 2023/12/08 | Science 37 Holdings effected a 1-for-20 reverse stock split. |
| 2024/03/12 | Date of transaction: disposition of Science 37 Holdings shares. |
| 2024/03/14 | Date of filing of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.